Refine
Year of publication
Document Type
- Article (733)
- Preprint (683)
- Conference Proceeding (6)
- Working Paper (5)
- Report (3)
- Doctoral Thesis (1)
Has Fulltext
- yes (1431)
Is part of the Bibliography
- no (1431)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- immunotherapy (6)
- COVID-19 (5)
- ALICE experiment (4)
- Breast cancer (4)
- Collective Flow (4)
- Diagnostic markers (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- cancer (4)
- child (4)
- children (4)
- lung cancer (4)
- ALICE (3)
- Bipolar disorder (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- Psychiatric disorders (3)
- biomarker (3)
- hematopoietic stem cell transplantation (3)
- pp collisions (3)
- radical prostatectomy (3)
- 140Ce (2)
- ADHD (2)
- Aspergillus fumigatus (2)
- Atrial fibrillation (2)
- Beauty production (2)
- COVID-19 surveillance (2)
- Cancer (2)
- Charm physics (2)
- Depression (2)
- Diagnostik (2)
- Drug therapy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Genetics (2)
- Heart failure (2)
- Heavy Quark Production (2)
- Hypertension (2)
- Immunology (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Mammakarzinom (2)
- NIRS (2)
- Nachsorge (2)
- Nuclear reactions (2)
- Omicron (2)
- Oncology (2)
- Outcome (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QCD (2)
- Rehabilitation (2)
- Richtlinie (2)
- SARS-CoV-2 monitoring (2)
- Shell model (2)
- Single electrons (2)
- Structural plasticity (2)
- Suicide (2)
- Superficial vein thrombosis (2)
- Surgery (2)
- Treatment (2)
- Ursus arctos (2)
- bipolar disorder (2)
- breast cancer (2)
- data science (2)
- diagnosis (2)
- follow‑up (2)
- functional outcome (2)
- guideline (2)
- inflammation (2)
- invasive fungal disease (2)
- leukemia (2)
- outcome (2)
- prostate cancer (2)
- psoriasis (2)
- screening (2)
- 16 segment AHA model (1)
- 19F (1)
- 900 GeV (1)
- ACL (1)
- AIS (1)
- AKI (1)
- AKT (1)
- ALICE detector (1)
- ARDS (1)
- Actin (1)
- Active middle ear implants (1)
- Acute coronary syndrome (1)
- Acute inflammation (1)
- Adjustment of dosage at steady state (1)
- Adult neurogenesis (1)
- Adverse events (1)
- Age groups (1)
- Amino acid analysis (1)
- Anlegerschutz (1)
- Annual General Meeting (1)
- Annual general meeting (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Antibody isotypes (1)
- Antifungal agents (1)
- Antigen-presenting cells (1)
- Antirheumatic agents (1)
- Aortic valve (1)
- Aortic valve replacement (1)
- Apes (1)
- Artesunate (1)
- Artificial Intelligence (1)
- Artificial intelligence (1)
- Aspergillosis (1)
- Aspergillus (1)
- Atomic and Molecular Physics (1)
- Auditory system (1)
- Autorschaft (1)
- Awareness campaign (1)
- B cell receptor (1)
- B.1.1.529 (1)
- BA.4 (1)
- BA.5 (1)
- BFIS (1)
- BI1361849 (1)
- Bacteria (1)
- Bankberatung (1)
- Behavior (1)
- Biliary tree (1)
- Biodiversity (1)
- Biodiversity Data (1)
- Biological (1)
- Biological heart valves (1)
- Biomarker (1)
- Biomarkers (1)
- Biomonitoring (1)
- Bioprosthesis (1)
- Blood pressure (1)
- Body mass index (1)
- Bone conduction devices (1)
- Bone metastases (1)
- Bone metastasis (1)
- Bone strength assessment (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Brain DNA methylation (1)
- Brain injury (1)
- Breast neoplasms (1)
- Breast tumors (1)
- Business strategy in drug development (1)
- CD3/19 depletion (1)
- CD34 selection (1)
- CD36 (1)
- CEO Speeches (1)
- CEO speeches (1)
- CHRNA10 (1)
- CHRNA7 (1)
- CHRNA9 (1)
- CIK cells (1)
- COMT (1)
- COVID 19 (1)
- CRPC (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- CTLA-4 (1)
- CV9202 (1)
- CVID (1)
- CWS Studiengruppe (1)
- Calcium (1)
- Cancer check up (1)
- Cancer detection (1)
- Cancer detection and diagnosis (1)
- Candida spp (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Cardiac surgery (1)
- Cardiac troponin (1)
- Cardiovascular biology (1)
- Cardiovascular disease risk (1)
- Cardiovascular diseases (1)
- Cardiovascular magnetic resonance (1)
- Catheter ablation (1)
- Cell binding (1)
- Cell membranes (1)
- Cell staining (1)
- Cellular imaging (1)
- Centrality Class (1)
- Centrality Selection (1)
- Cherenkov counter: lead-glass (1)
- Child (1)
- Child abuse (1)
- Children (1)
- Chronic obstructive pulmonary disease (1)
- Circadian (1)
- Clinical Trials and Observations (1)
- Clinical genetics (1)
- Clinical study (1)
- Clinical trial (1)
- Clinical variation (1)
- Closure (1)
- Cohort studies (1)
- Coincidence measurement (1)
- Collective Flow, (1)
- Combo® DTS (1)
- Community ecology (1)
- Comparative effectiveness research (1)
- Comparison with QCD (1)
- Complexity (1)
- Computational models (1)
- Computational science (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computer-aided drug design (1)
- Congenital anomalies (1)
- Consensus (1)
- Consensus document (1)
- Consensus statement (1)
- Conservation (1)
- Conservation biology (1)
- Critical care (1)
- Cryoballoon (1)
- Cryoelectron microscopy (1)
- Cryoelectron tomography (1)
- DNA sequence analysis (1)
- DNA-PAINT (1)
- DYT1 (1)
- Death rates (1)
- Dendritic spines (1)
- Denosumab (1)
- Dermatomyositis (1)
- Detection workflow (1)
- Developmental programming (1)
- Diagnosis (1)
- Digital breast tomosynthesis (DBT) (1)
- Digital mammography (1)
- Digitization (1)
- Dilated cardiomyopathy (1)
- Diphosphonates (1)
- Direct reactions (1)
- Dopamine (1)
- Drug screens (1)
- Dynamical systems (1)
- Early (prenatal and postnatal) life experiences (1)
- Ecological networks (1)
- Ecology (1)
- Ecosystem ecology (1)
- Ejection fraction (1)
- Elderly (1)
- Electromagnetic transitions (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Embryos (1)
- Employment (1)
- Ena/VASP proteins (1)
- Endothelium (1)
- Entorhinal cortex lesion (1)
- Environmental enrichment (1)
- Environmental impact (1)
- Enzyme-linked immunoassays (1)
- Epilepsy (1)
- Europe (1)
- European Society for Immunodeficiencies (ESID) (1)
- Everolimus (1)
- Excitability (1)
- Exercise training (1)
- Exosomes (1)
- Experimental Finance (1)
- Extended donor criteria (1)
- FBS (1)
- FFLU (1)
- FGFR (1)
- Falciparum (1)
- Femoral neck (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Financial Advice (1)
- Finanzbildung (1)
- Fistula (1)
- Flow cytometry (1)
- Follow-up (1)
- Fondaparinux (1)
- Forschung (1)
- Fracture risk (1)
- Frailty (1)
- Functional outcome (1)
- Functional outcomes (1)
- FungiScope® registry (1)
- GPS collar (1)
- Gene expression (1)
- General practitioners (1)
- Genetic causes of cancer (1)
- Genetic testing (1)
- German PID-NET registry (1)
- Global positioning system (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- Guidelines (1)
- HADES (1)
- HBT (1)
- HER2-positive (1)
- HNO (1)
- HPV-positive OPSCC (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hard Scattering (1)
- Health policy (1)
- Heart (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Hematologic malignancies (1)
- Hematology (1)
- Hepatocellular carcinoma (1)
- Herafill (1)
- Herbaria (1)
- High-energy neutron detection (1)
- Histology (1)
- Household Finance (1)
- Human behaviour (1)
- Human genetics (1)
- Hypofractionated radiotherapy (1)
- ICU (1)
- IFN-β (1)
- ISS (1)
- IgG substitution therapy (1)
- Immune response (1)
- Immunity (1)
- Immunoassays (1)
- Immunogenetics (1)
- Immunology and Microbiology Section (1)
- Immunomonitoring (1)
- Implantable cardioverter-defibrillator (1)
- Inclusive spectra (1)
- Inflammation (1)
- Intensity interferometry (1)
- Interleukin-17A (1)
- Intra-abdominal infection (1)
- Invariant Mass Distribution (1)
- Invasive candidiasis (1)
- Invasive fungal infections (1)
- Inverse kinematics (1)
- Ionisation energy loss (1)
- Isoproterenol (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jurkat (1)
- K48-linked (1)
- K63-linked (1)
- KDIGO (1)
- KOOS IV (1)
- Kidney (1)
- Knochendefektheilung (1)
- Kupffer cells (1)
- Köcherfliegen (1)
- LASS (1)
- LFP (1)
- Laparostomy (1)
- Lee-type (1)
- Lehre (1)
- Leukemias (1)
- Library screening (1)
- Lipid signaling (1)
- Literarischer Stil (1)
- Literaturwissenschaft (1)
- Lomentospora prolificans (1)
- Low-molecular-weight heparin (1)
- Luciferase (1)
- Lumbar spine (1)
- Lymphoid Neoplasia (1)
- MACS (1)
- Machine learning (1)
- Macrophages (1)
- Malaria (1)
- Malignancy (1)
- Market Efficiency (1)
- Market efficiency (1)
- Masquelet (1)
- Masquelet technique (1)
- Material budget (1)
- Maternal separation (1)
- Mena/VASP (1)
- Mental health and psychiatry (1)
- Mesh (1)
- Metagenomics (1)
- MicroRNAs (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Mittelhessen (1)
- Mixed hearing loss (1)
- Models & methods for nuclear reactions (1)
- Molecular neuroscience (1)
- Monitoring (1)
- Monte Carlo (1)
- Motor control (1)
- Mouse models (1)
- Multi-Parton Interactions (1)
- Multi-neutron detection (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multimodal imaging (1)
- Multiparametric MRI (1)
- Multiple sclerosis (1)
- Multivariate analysis (1)
- Mutation databases (1)
- Mycoses (1)
- Myocardial infarction (1)
- Myocardial perfusion (1)
- Myocardial segmentation (1)
- NADPH oxidase (1)
- NMR spectroscopy (1)
- NSG mice (1)
- NVBP (1)
- Neoadjuvant therapy (1)
- Neural network (1)
- Neuroinflammation (1)
- Neuroscience (1)
- Neutron physics (1)
- Neutropenia (1)
- Non-small cell lung cancer (1)
- Non-trauma (1)
- Nordhessen (1)
- Nox1 (1)
- NoxO1 (1)
- Nuclear modification factor (1)
- Nuclear resonance fluorescence (1)
- Nuclear structure & decays (1)
- Nucleon induced nuclear reactions (1)
- Nutrition (1)
- ORL (1)
- Observational (1)
- Oldest-old (1)
- Open abdomen (1)
- Organ allocation (1)
- Osteoporosis diagnosis (1)
- Otorhinolaryngology (1)
- Outcome assessment (1)
- Outpatients (1)
- Ovarian cancer (1)
- P2X7 receptor (1)
- PD-1 (1)
- PD-L1 (1)
- PID prevalence (1)
- PKD (1)
- PKD/IC (1)
- PRRT2 (1)
- PSA screening (1)
- PSA-Screening (1)
- PYTHIA (1)
- Pacemaker (1)
- Paediatric research (1)
- Pancreas transplantation (1)
- Pancreatitis (1)
- Pandemic (1)
- Particle and Resonance Production (1)
- Pathological complete response (1)
- Pb–Pb (1)
- Pediatric infections (1)
- Pediatric patients (1)
- Pediatrics (1)
- Peritoneal macrophages (1)
- Peritonitis (1)
- Personalized medicine (1)
- Phosphorylation (1)
- Physical activity (1)
- Plasmodium (1)
- Plastic scintillator array (1)
- Pneumonia (1)
- Population-based screening (1)
- Post treatment (1)
- Post-traumatic stress disorder (1)
- Predictive markers (1)
- Prevention (1)
- Preventive medicine (1)
- Production Cross Section (1)
- Prognosis (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- Prostata-specific antigen (1)
- Prostataspezifisches Antigen (1)
- Prostate cancer (1)
- Proteinkinase (1)
- Proton–proton (1)
- Prävention (1)
- Pseudo HE-images (1)
- Psychiatry (1)
- Psychological and psychosocial issues (1)
- Pygmy Dipole Resonance (1)
- Quality of life (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Quasi-free scattering (1)
- Quasi-particle phonon model (1)
- Quinine (1)
- REMS (1)
- RNA (1)
- RTS (1)
- Radiative capture (1)
- Radical prostatectomy (1)
- Radiofrequency (1)
- Radiomics (1)
- Raman spectroscopy (1)
- Rapidity Range (1)
- Re-exploration (1)
- Re-injury (1)
- Reactions with relativistic radioactive beams (1)
- Reactive oxygen species (1)
- Recall rate (1)
- Recurrence (1)
- Registries (1)
- Rehospitalization (1)
- Reintervention (1)
- Rejection (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Renal replacement therapy (1)
- Research (1)
- Research Infrastructure (1)
- Residency (1)
- Resolution Parameter (1)
- Resonance reactions (1)
- Return to play (1)
- Return to sports (1)
- Rhabdomyoma (1)
- Rhabdomyosarcoma (1)
- Risk assessment (1)
- Ryanodine (1)
- SARS CoV 2 (1)
- SARS-CoV-2 (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SMAD (1)
- Saarland (1)
- Scedosporium spp. (1)
- Seasonal variation (1)
- Secondary prevention (1)
- Seizure (1)
- Semantics (1)
- Sensory systems (1)
- Serine proteases (1)
- Severe malaria (1)
- Single muons (1)
- Small molecules (1)
- Solar insolation (1)
- South West Germany (1)
- Specialist training (1)
- Spectrin (1)
- Spectroscopic factors (1)
- Spectroscopic factors & electromagnetic moments (1)
- Stress vulnerability/resilience genes (1)
- Sub-segmentation (1)
- Sunlight (1)
- Superoxide (1)
- Survival analysis (1)
- Sustainable Finance (1)
- Synaptic plasticity (1)
- Synaptopodin (1)
- Synthetic (1)
- Systematic Uncertainty (1)
- T-cell (1)
- TAVI (1)
- TGF-beta (1)
- TGFB-induced factor homeobox 1 (1)
- TGFβ (1)
- TGIF (1)
- TOR1A (1)
- TR (1)
- Taxonomy (1)
- Tea (1)
- Teaching (1)
- Technical data (1)
- Technique (1)
- Textual Analysis (1)
- Textual Sentiment (1)
- Textual analysis (1)
- Textual sentiment (1)
- Therapeutics (1)
- Therapy (1)
- Thoracic trauma (1)
- Time Projection Chamber (1)
- Timing (1)
- Tracking (1)
- Transcriptome analysis (1)
- Transition radiation detector (1)
- Translation (1)
- Transverse momentum (1)
- Trauma (1)
- Trigger (1)
- Triple negative (1)
- Two-hit hypothesis (1)
- Ultrasound (1)
- University hospitals (1)
- Universitätskliniken (1)
- Urinary continence (1)
- Urinary incontinence (1)
- VASP (1)
- VEGF receptor 2 internalization and signaling (1)
- Variant of concern (1)
- Vascular emergencies (1)
- Vector Boson Production (1)
- Venous thrombosis (1)
- Vesicles (1)
- Voriconazole (1)
- Vorsorgeuntersuchung (1)
- Wastewater-based epidemiology (WBE) (1)
- Weiterbildung (1)
- X-ray crystallography (1)
- Xenon-based gas mixture (1)
- Z-inspection (1)
- accessory proteins (1)
- activity sensors (1)
- acute lymphoblastic leukemia (1)
- adenocarcinoma (1)
- alcoholic hepatitis (1)
- allogeneic stem cell transplant (1)
- allogeneic stem cell transplantation (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- animal personality (1)
- anti-EGFR therapy (1)
- antibiotic resistance (1)
- antibodies (1)
- antifungal combination therapy (1)
- antifungal therapy (1)
- aortic stenosis (1)
- apex (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- artifacts (1)
- artificial intelligence (1)
- astrocytes (1)
- atherosclerosis (1)
- attention deficit hyperactivity disorder (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- autoantibodies (1)
- b-cell lymphomas (1)
- bacteremia (1)
- behavioural syndrome (1)
- bendamustine (1)
- bioactivity testing (1)
- biodiversity (1)
- biogeographic legaciese (1)
- bloodstream infections (1)
- bone marrow derived mononuclear cells (1)
- bone marrow mononuclear cells (1)
- brain injury (1)
- brown bear (1)
- cAMP (1)
- cGMP (1)
- calcium-independent phospholipase A2β (1)
- calorimeter: electromagnetic (1)
- calretinin (1)
- candidemia (1)
- capture (1)
- cardiac magnetic resonance (1)
- castration resistance (1)
- cell lines (1)
- cell stress (1)
- cell-free protein synthesis (1)
- central nervous system (1)
- ceramide synthase (1)
- ceramides (1)
- cerium (1)
- chemorefractory metastatic colorectal cancer (1)
- chemotherapy (1)
- chemotherapy regimen (1)
- chimeric antigen receptor (CAR) (1)
- chimeric antigen receptor t-cell therapy (1)
- chimeric antigen receptors (1)
- cholestasis (1)
- chronic kidney disease (1)
- chronic total occlusion (1)
- cisplatin (1)
- clinical research (1)
- cohort study (1)
- colon (1)
- combined modality therapy (1)
- component study (1)
- coronary disease (1)
- critical size defect (1)
- cross-section (1)
- cytokine (1)
- dE/dx (1)
- damage detection (1)
- data quality (1)
- decision aids (1)
- delirium (1)
- dementia (1)
- dentate gyrus (1)
- depression (1)
- detector (1)
- diagnostics (1)
- disease prevalence (1)
- disease progression (1)
- double hierarchical model (1)
- double immune checkpoint inhibition (1)
- early recognition (1)
- easyPACId (1)
- ecological and phytosociological classification (1)
- ectosomes (1)
- electroencephalography (EEG) (1)
- electronics: readout (1)
- endocannabinoids (1)
- endothelial cells (1)
- entorhinal cortex lesion (1)
- ethical co-design (1)
- ethics (1)
- excitation transport (1)
- exosomes (1)
- experimental results (1)
- extracellular vesicles (1)
- facial nerve functional outcome (1)
- familial infantile epilepsy (1)
- fatigue testing (1)
- fibre: optical (1)
- fibrosis (1)
- flow cytometry (1)
- fluorine (1)
- fondaparinux (1)
- forest classification (1)
- forest functional similarity (1)
- fragment-based screening (1)
- galactomannan (1)
- gene expression (1)
- genetic phenotypes (1)
- geriatric medicine (1)
- glass fiber reinforced materials (1)
- guidelines (1)
- head and neck neoplasms (1)
- head-and-neck cancer (1)
- healthcare (1)
- hearing nerve (1)
- heavy ion experiments (1)
- hematopoietic cell transplantation (1)
- hemiplegic migraine (1)
- homeostatic synaptic scaling (1)
- human natural killer cell (1)
- human subjects (1)
- hypertension and anti-hypertensive treatment (1)
- imaging (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitor (ICI) (1)
- immune monitoring (1)
- immune reconstitution (1)
- immunohistochemistry (1)
- impulsivity (1)
- incontinence (1)
- induced membrane (1)
- induction therapy (1)
- infants (1)
- infection (1)
- infections (1)
- inflammasome (1)
- intensive care admission and mortality (1)
- interferon regulatory factor 9 (IRF9) (1)
- interleukin-1β (1)
- interoperability (1)
- intratumoral (1)
- intrinsically disordered region (1)
- invasive mold infection (1)
- layer-specificity (1)
- learning loss (1)
- leukapheresis (1)
- light harvesting networks (1)
- light–energy conversion (1)
- lipids (1)
- lipiodol (1)
- lipoxin A4 (1)
- liver metastasis (1)
- low molecular weight heparin (1)
- low-dose imaging (1)
- lymphoma (1)
- mRNA active cancer immunotherapy (1)
- mTOR (1)
- mTOR inhibitor (1)
- machine learning (1)
- magnetic resonance imaging of the brain (1)
- major depression (1)
- malignant melanoma (1)
- mast cells (1)
- mechanical accuracy (1)
- membranous urethra (1)
- mesenchymal stromal cells (1)
- metabolic syndrome (1)
- metastasis (1)
- metastatic prostate cancer (1)
- microparticles (1)
- microsurgical treatment (1)
- microvesicles (1)
- microwave ablation (1)
- mid-term urinary continence (1)
- mindfulness (1)
- minimal information requirements (1)
- misallocation rate (1)
- misinterpretation rate (1)
- mitral regurgitation (1)
- mitral valve surgery (1)
- mortality (1)
- movement (1)
- multicenter study (1)
- multiparametric magnetic resonance imaging (1)
- multivariate mixed model (1)
- myocardial fibrosis (1)
- n_TOF (1)
- natural products (1)
- neonates (1)
- nerve-sparing surgery (1)
- neurofeedback (1)
- neutron (1)
- neutropenia (1)
- non-ST-segment elevation acute coronary syndrome (1)
- non-neutropenic episode (1)
- nonstructural proteins (1)
- nucleosynthesis (1)
- obesity (1)
- olfaction (1)
- open quantum systems (1)
- optical coherence tomography (1)
- organ preservation (1)
- organotypic slice cultures (1)
- overlooking rate (1)
- p47phox (1)
- pad-test (1)
- patients (1)
- pediatric patients (1)
- penile cancer (1)
- perforant path transection (1)
- perforin (1)
- personality (1)
- phagocytosis (1)
- phantom study (1)
- phenotypic spectrum (1)
- phylogenetic community distance (1)
- pneumonia (1)
- polygenic risk score (1)
- polymerase chain reaction (1)
- polyubiquitin (1)
- preclinical (1)
- primary biliary cholangitis (1)
- primary biliary cirrhosis (1)
- primary immunodeficiency (PID) (1)
- primary sclerosing cholangitis (1)
- proteins (1)
- proteobacteria (1)
- proteomics (1)
- psychotherapy process (1)
- quantum transport (1)
- quark gluon plasma (1)
- radar-based structural health monitoring (1)
- randomized controlled trial (RCT) (1)
- re-exposure (1)
- rechallenge (1)
- registry for primary immunodeficiency (1)
- reintroduction (1)
- repeatability (1)
- reproducibility (1)
- residual intra‐individual variability (1)
- resolution (1)
- resolution of inflammation (1)
- rhabdomyosarcoma (1)
- rigor (1)
- risk assessment (1)
- rituximab (1)
- robot-guided stereotaxy (1)
- s-process (1)
- sarcoma (1)
- scaffold size (1)
- scar (1)
- schizophrenia (1)
- school closure (1)
- second line therapy (1)
- secukinumab (1)
- semiconductors (1)
- simplified production (1)
- single subject classification (1)
- sleep disordered breathing (1)
- smart home (1)
- smart living (1)
- solid tumor (1)
- specialized pro-resolving lipid mediators (SPMs) (1)
- species differences (1)
- spectra (1)
- sprouting angiogenesis (1)
- stability (1)
- standardization (1)
- stereotactic frame (1)
- stereotactic neurosurgery (1)
- stroke (1)
- structural proteins (1)
- student achievement (1)
- survival (1)
- systematic review (1)
- tandem mass spectrometry (1)
- targeted therapy (1)
- telmisartan (1)
- temporal classification (1)
- therapeutic alliance (1)
- tip cell filopodia formation (1)
- toll-like receptor (1)
- tomography (1)
- treatment (1)
- treatment resistance (1)
- treatment response (1)
- tropical forests (1)
- trustworthy AI (1)
- trustworthy AI Co-design (1)
- tumor (1)
- tumor microenvironment (1)
- tumor microenvironment (TME) (1)
- type I interferons (IFNs) (1)
- tyrosine kinase inhibitor (TKI) (1)
- ubiquitin-conjugating enzymes (1)
- urinary incontinence (1)
- ursodeoxycholic acid (1)
- uveal melanoma (1)
- variant of concern (1)
- vascular calcification (1)
- vascular dysfunction and inflammation (1)
- vegetation monitoring (1)
- venous thrombosis (1)
- versican (VCAN) (1)
- vestibular schwannoma (1)
- viral tracing (1)
- virtual reality (1)
- wastewater-based epidemiology (WBE) (1)
- web of things (1)
- weed communities (1)
- wind turbine blades (1)
- Öffentlichkeit (1)
- ß-D-glucan (1)
- γ-ray spectroscopy (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1125)
- Frankfurt Institute for Advanced Studies (FIAS) (958)
- Informatik (925)
- Medizin (189)
- Geowissenschaften (48)
- Biowissenschaften (9)
- ELEMENTS (8)
- Biochemie, Chemie und Pharmazie (7)
- Georg-Speyer-Haus (6)
- Institut für Ökologie, Evolution und Diversität (6)
Inclusive, prompt and non-prompt J/ψ production at midrapidity in p-Pb collisions at √sNN = 5.02 TeV
(2022)
A measurement of inclusive, prompt, and non-prompt J/ψ production in p-Pb collisions at a nucleon-nucleon centre-of-mass energy sNN−−−√ = 5.02 TeV is presented. The inclusive J/ψ mesons are reconstructed in the dielectron decay channel at midrapidity down to a transverse momentum pT = 0. The inclusive J/ψ nuclear modification factor RpPb is calculated by comparing the new results in p-Pb collisions to a recently measured proton-proton reference at the same centre-of-mass energy. Non-prompt J/ψ mesons, which originate from the decay of beauty hadrons, are separated from promptly produced J/ψ on a statistical basis for pT larger than 1.0 GeV/c. These results are based on the data sample collected by the ALICE detector during the 2016 LHC p-Pb run, corresponding to an integrated luminosity Lint = 292 ± 11 μb−1, which is six times larger than the previous publications. The total uncertainty on the pT-integrated inclusive J/ψ and non-prompt J/ψ cross section are reduced by a factor 1.7 and 2.2, respectively. The measured cross sections and RpPb are compared with theoretical models that include various combinations of cold nuclear matter effects. From the non-prompt J/ψ production cross section, the bb¯¯¯ production cross section at midrapidity, dσbb¯¯¯/dy, and the total cross section extrapolated over full phase space, σbb¯¯¯, are derived.
The inclusive J/ψ elliptic (v2) and triangular (v3) flow coefficients measured at forward rapidity (2.5 < y < 4) and the v2 measured at midrapidity (|y| < 0.9) in Pb-Pb collisions at sNN−−−√ = 5.02 TeV using the ALICE detector at the LHC are reported. The entire Pb-Pb data sample collected during Run 2 is employed, amounting to an integrated luminosity of 750 μb−1 at forward rapidity and 93 μb−1 at midrapidity. The results are obtained using the scalar product method and are reported as a function of transverse momentum pT and collision centrality. At midrapidity, the J/ψ v2 is in agreement with the forward rapidity measurement. The centrality averaged results indicate a positive J/ψ v3 with a significance of more than 5σ at forward rapidity in the pT range 2 < pT < 5 GeV/c. The forward rapidity v2, v3, and v3/v2 results at low and intermediate pT (pT ≲ 8 GeV/c) exhibit a mass hierarchy when compared to pions and D mesons, while converging into a species-independent curve at higher pT. At low and intermediate pT, the results could be interpreted in terms of a later thermalization of charm quarks compared to light quarks, while at high pT, path-length dependent effects seem to dominate. The J/ψ v2 measurements are further compared to a microscopic transport model calculation. Using a simplified extension of the quark scaling approach involving both light and charm quark flow components, it is shown that the D-meson vn measurements can be described based on those for charged pions and J/ψ flow.
The invariant differential cross section of inclusive ω(782) meson production at midrapidity (|y|<0.5) in pp collisions at s√=7TeV was measured with the ALICE detector at the LHC over a transverse momentum range of 2<pT<17GeV/c. The ω meson was reconstructed via its ω→π+π−π0 decay channel. The measured ω production cross section is compared to various calculations: PYTHIA 8.2 Monash 2013 describes the data, while PYTHIA 8.2 Tune 4C overestimates the data by about 50%. A recent NLO calculation, which includes a model describing the fragmentation of the whole vector-meson nonet, describes the data within uncertainties below 6GeV/c, while it overestimates the data by up to 50% for higher pT. The ω/π0 ratio is in agreement with previous measurements at lower collision energies and the PYTHIA calculations. In addition, the measurement is compatible with transverse mass scaling within the measured pT range and the ratio is constant with Cω/π0=0.67±0.03~(stat)~±0.04~(sys)~ above a transverse momentum of 2.5GeV/c.
Two-particle angular correlations are measured in high-multiplicity proton-proton collisions at s√ = 13 TeV by the ALICE Collaboration. The yields of particle pairs at short-(∆η ∼ 0) and long-range (1.6 < |∆η| < 1.8) in pseudorapidity are extracted on the near-side (∆φ ∼ 0). They are reported as a function of transverse momentum (pT) in the range 1 < pT < 4 GeV/c. Furthermore, the event-scale dependence is studied for the first time by requiring the presence of high-pT leading particles or jets for varying pT thresholds. The results demonstrate that the long-range “ridge” yield, possibly related to the collective behavior of the system, is present in events with high-pT processes as well. The magnitudes of the short- and long-range yields are found to grow with the event scale. The results are compared to EPOS LHC and PYTHIA 8 calculations, with and without string-shoving interactions. It is found that while both models describe the qualitative trends in the data, calculations from EPOS LHC show a better quantitative agreement for the pT dependency, while overestimating the event-scale dependency.
The production of π±, K±, K0S, K∗(892)0, p, ϕ(1020), Λ, Ξ−, Ω−, and their antiparticles was measured in inelastic proton–proton (pp) collisions at a center-of-mass energy of s√ = 13 TeV at midrapidity (|y|<0.5) as a function of transverse momentum (pT) using the ALICE detector at the CERN LHC. Furthermore, the single-particle pT distributions of K0S, Λ, and Λ¯¯¯¯ in inelastic pp collisions at s√=7 TeV are reported here for the first time. The pT distributions are studied at midrapidity within the transverse momentum range 0≤pT≤20 GeV/c, depending on the particle species. The pT spectra, integrated yields, and particle yield ratios are discussed as a function of collision energy and compared with measurements at lower s√ and with results from various general-purpose QCD-inspired Monte Carlo models. A hardening of the spectra at high pT with increasing collision energy is observed, which is similar for all particle species under study. The transverse mass and xT≡2pT/s√ scaling properties of hadron production are also studied. As the collision energy increases from s√ = 7–13 TeV, the yields of non- and single-strange hadrons normalized to the pion yields remain approximately constant as a function of s√, while ratios for multi-strange hadrons indicate enhancements. The pT-differential cross sections of π±, K± and p (p¯¯¯) are compared with next-to-leading order perturbative QCD calculations, which are found to overestimate the cross sections for π± and p (p¯¯¯) at high pT.
Inclusive ψ(2S) production is measured in p-Pb collisions at the centre-of-mass energy per nucleon-nucleon pair sNN−−−√ = 8.16 TeV, using the ALICE detector at the CERN LHC. The production of ψ(2S) is studied at forward (2.03 < ycms < 3.53) and backward (−4.46 < ycms < −2.96) centre-of-mass rapidity and for transverse momentum pT < 12 GeV/c via the decay to muon pairs. In this paper, we report the integrated as well as the ycms- and pT-differential inclusive production cross sections. Nuclear effects on ψ(2S) production are studied via the determination of the nuclear modification factor that shows a strong suppression at both forward and backward centre-of-mass rapidities. Comparisons with corresponding results for inclusive J/ψ show a similar suppression for the two states at forward rapidity (p-going direction), but a stronger suppression for ψ(2S) at backward rapidity (Pb-going direction). As a function of pT, no clear dependence of the nuclear modification factor is found. The relative size of nuclear effects on ψ(2S) production compared to J/ψ is also studied via the double ratio of production cross sections [σψ(2S)/σJ/ψ]pPb/[σψ(2S)/σJ/ψ]pp between p-Pb and pp collisions. The results are compared with theoretical models that include various effects related to the initial and final state of the collision system and also with previous measurements at sNN−−−√ = 5.02 TeV.
The transverse momentum (pT) differential cross section of the charm-strange baryon Ξ0c is measured at midrapidity (|y| < 0.5) via its semileptonic decay into e+Ξ−νe in pp collisions at s√ = 5.02 TeV with the ALICE detector at the LHC. The ratio of the pT-differential Ξ0c-baryon and D0-meson production cross sections is also reported. The measurements are compared with simulations with different tunes of the PYTHIA 8 event generator, with predictions from a statistical hadronisation model (SHM) with a largely augmented set of charm-baryon states beyond the current lists of the Particle Data Group, and with models including hadronisation via quark coalescence. The pT-integrated cross section of prompt Ξ0c-baryon production at midrapidity is also reported, which is used to calculate the baryon-to-meson ratio Ξ0c/D0 = 0.20 ± 0.04 (stat.)+0.08−0.07 (syst.). These results provide an additional indication of a modification of the charm fragmentation from e+e− and e−p collisions to pp collisions.
The production of ϕ mesons has been studied in pp collisions at LHC energies with the ALICE detector via the dimuon decay channel in the rapidity region 2.5<y<4. Measurements of the differential cross section d2σ/dydpT are presented as a function of the transverse momentum (pT) at the center-of-mass energies s√=5.02, 8 and 13 TeV and compared with the ALICE results at midrapidity. The differential cross sections at s√=5.02 and 13 TeV are also studied in several rapidity intervals as a function of pT, and as a function of rapidity in three pT intervals. A hardening of the pT-differential cross section with the collision energy is observed, while, for a given energy, pT spectra soften with increasing rapidity and, conversely, rapidity distributions get slightly narrower at increasing pT. The new results, complementing the published measurements at s√=2.76 and 7 TeV, allow one to establish the energy dependence of ϕ meson production and to compare the measured cross sections with phenomenological models. None of the considered models manages to describe the evolution of the cross section with pT and rapidity at all the energies.
Measurements of event-by-event fluctuations of charged-particle multiplicities in Pb–Pb collisions at sNN−−−√ = 2.76 TeV using the ALICE detector at the CERN Large Hadron Collider (LHC) are presented in the pseudorapidity range |η|<0.8 and transverse momentum 0.2<pT<2.0 GeV/c. The amplitude of the fluctuations is expressed in terms of the variance normalized by the mean of the multiplicity distribution. The η and pT dependences of the fluctuations and their evolution with respect to collision centrality are investigated. The multiplicity fluctuations tend to decrease from peripheral to central collisions. The results are compared to those obtained from HIJING and AMPT Monte Carlo event generators as well as to experimental data at lower collision energies. Additionally, the measured multiplicity fluctuations are discussed in the context of the isothermal compressibility of the high-density strongly-interacting system formed in central Pb–Pb collisions.
The pT-differential production cross sections of prompt and non-prompt (produced in beauty-hadron decays) D mesons were measured by the ALICE experiment at midrapidity (|y| < 0.5) in proton-proton collisions at s√ = 5.02 TeV. The data sample used in the analysis corresponds to an integrated luminosity of (19.3 ± 0.4) nb−1. D mesons were reconstructed from their decays D0 → K−π+, D+ → K−π+π+, and D+s→φπ+→K−K+π+ and their charge conjugates. Compared to previous measurements in the same rapidity region, the cross sections of prompt D+ and D+s mesons have an extended pT coverage and total uncertainties reduced by a factor ranging from 1.05 to 1.6, depending on pT, allowing for a more precise determination of their pT-integrated cross sections. The results are well described by perturbative QCD calculations. The fragmentation fraction of heavy quarks to strange mesons divided by the one to non-strange mesons, fs/(fu + fd), is compatible for charm and beauty quarks and with previous measurements at different centre-of-mass energies and collision systems. The bb¯¯¯ production cross section per rapidity unit at midrapidity, estimated from non-prompt D-meson measurements, is dσbb¯¯¯/dy∣∣|y|<0.5=34.5±2.4(stat)+4.7−2.9(tot.syst) μb. It is compatible with previous measurements at the same centre-of-mass energy and with the cross section pre- dicted by perturbative QCD calculations.
Higher harmonic non-linear flow modes of charged hadrons in Pb-Pb collisions at √sNN = 5.02 TeV
(2020)
Anisotropic flow coefficients, vn, non-linear flow mode coefficients, χn,mk, and correlations among different symmetry planes, ρn,mk are measured in Pb-Pb collisions at sNN−−−√ = 5.02 TeV. Results obtained with multi-particle correlations are reported for the transverse momentum interval 0.2 < pT < 5.0 GeV/c within the pseudorapidity interval 0.4 < |η| < 0.8 as a function of collision centrality. The vn coefficients and χn,mk and ρn,mk are presented up to the ninth and seventh harmonic order, respectively. Calculations suggest that the correlations measured in different symmetry planes and the non-linear flow mode coefficients are dependent on the shear and bulk viscosity to entropy ratios of the medium created in heavy-ion collisions. The comparison between these measurements and those at lower energies and calculations from hydrodynamic models places strong constraints on the initial conditions and transport properties of the system.
The first experimental information on the strong interaction between Λ and Ξ− strange baryons is presented in this Letter. The correlation function of Λ−Ξ− and Λ¯¯¯¯−Ξ¯¯¯¯+ pairs produced in high-multiplicity proton-proton (pp) collisions at s√ = 13 TeV at the LHC is measured as a function of the relative momentum of the pair. The femtoscopy method is used to calculate the correlation function, which is then compared with theoretical expectations obtained using a meson exchange model, chiral effective field theory, and Lattice QCD calculations close to the physical point. Data support predictions of small scattering parameters while discarding versions with large ones, thus suggesting a weak Λ−Ξ− interaction. The limited statistical significance of the data does not yet allow one to constrain the effects of coupled channels like Σ−Ξ and N−Ω.
Polarization of Λ and ¯Λ hyperons along the beam direction in Pb–Pb collisions at √sNN = 5.02 TeV
(2022)
The polarization of the Λ and Λ¯¯¯¯ hyperons along the beam (z) direction, Pz, has been measured in Pb-Pb collisions at sNN−−−√ = 5.02TeV recorded with ALICE at the Large Hadron Collider (LHC). The main contribution to Pz comes from elliptic flow induced vorticity and can be characterized by the second Fourier sine coefficient Pz,s2=⟨Pzsin(2φ−2Ψ2)⟩, where φ is the hyperon azimuthal emission angle, and Ψ2 is the elliptic flow plane angle. We report the measurement of Pz,s2 for different collision centralities, and in the 30-50% centrality interval as a function of the hyperon transverse momentum and rapidity. The Pz,s2 is positive similarly as measured by the STAR Collaboration in Au-Au collisions at sNN−−−√ = 200 GeV, with somewhat smaller amplitude in the semi-central collisions. This is the first experimental evidence of a non-zero hyperon Pz in Pb-Pb collisions at the LHC. The comparison of the measured Pz,s2 with the hydrodynamic model calculations shows sensitivity to the competing contributions from thermal and the recently found shear induced vorticity, as well as to whether the polarization is acquired at the quark-gluon plasma or the hadronic phase.
Two-particle azimuthal correlations are measured with the ALICE apparatus in pp collisions at s√=13 TeV to explore strangeness- and multiplicity-related effects in the fragmentation of jets and the transition regime between bulk and hard production, probed with the condition that a strange meson (K0S) or a baryon (Λ) with transverse momentum pT>3 GeV/c is produced. Azimuthal correlations between kaons or Λ hyperons with other hadrons are presented at midrapidity for a broad range of the trigger (3<ptriggT<20 GeV/c) and associated particle pT (1 GeV/c <passocT<ptriggT), for minimum-bias events and as a function of the event multiplicity. The near- and away-side peak yields are compared for the case of either K0S or Λ(Λ¯¯¯¯) being the trigger particle with that of inclusive hadrons (a sample dominated by pions). In addition, the measurements are compared with predictions from PYTHIA 8 and EPOS LHC event generators.
Two-particle azimuthal correlations are measured with the ALICE apparatus in pp collisions at s√=13 TeV to explore strangeness- and multiplicity-related effects in the fragmentation of jets and the transition regime between bulk and hard production, probed with the condition that a strange meson (K0S) or baryon (Λ) with transverse momentum pT>3 GeV/c is produced. Azimuthal correlations between kaons or Λ hyperons with other hadrons are presented at midrapidity for a broad range of the trigger (3<ptriggT<20 GeV/c) and associated particle pT (1 GeV/c <passocT<ptriggT), for minimum-bias events and as a function of the event multiplicity. The near- and away-side peak yields are compared for the case of either K0S or Λ(Λ¯¯¯¯) being the trigger particle with that of inclusive hadrons (a sample dominated by pions). In addition, the measurements are compared with predictions from PYTHIA 8 and EPOS LHC event generators.
The production of K∗(892)0 and ϕ(1020) resonances has been measured in p-Pb collisions at sNN−−−√ = 8.16 TeV using the ALICE detector. Resonances are reconstructed via their hadronic decay channels in the rapidity interval −0.5 < y < 0 and the transverse momentum spectra are measured for various multiplicity classes up to pT = 20 GeV/c for K∗(892)0 and pT = 16 GeV/c for ϕ(1020). The pT -integrated yields and mean transverse momenta are reported and compared with previous results in pp, p-Pb and Pb-Pb collisions. The xT scaling for K∗(892)0 and ϕ(1020) resonance production is newly tested in p-Pb collisions and found to hold in the high-pT region at LHC energies. The nuclear modification factors (RpPb) as a function of pT for K∗0 and ϕ at sNN−−−−√ = 8.16 TeV are presented along with the new RpPb measurements of K∗0, ϕ , Ξ, and Ω at sNN−−−√ = 5.02 TeV. At intermediate pT (2-8 GeV/c), RpPb of Ξ, Ω show a Cronin-like enhancement, while K∗0 and ϕ show no or little nuclear modification. At high pT (> 8 GeV/c), the RpPb values of all hadrons are consistent with unity within uncertainties. The RpPb of K∗(892)0 and ϕ(1020) at sNN−−−√ = 8.16 and 5.02 TeV show no significant energy dependence.
The production of K∗(892)0 and ϕ(1020) resonances has been measured in p-Pb collisions at sNN−−−√ = 8.16 TeV using the ALICE detector. Resonances are reconstructed via their hadronic decay channels in the rapidity interval −0.5 < y < 0 and the transverse momentum spectra are measured for various multiplicity classes up to pT = 20 GeV/c for K∗(892)0 and pT = 16 GeV/c for ϕ(1020). The pT -integrated yields and mean transverse momenta are reported and compared with previous results in pp, p-Pb and Pb-Pb collisions. The xT scaling for K∗(892)0 and ϕ(1020) resonance production is newly tested in p-Pb collisions and found to hold in the high-pT region at Large Hadron Collider energies. The nuclear modification factors (RpPb) as a function of pT for K∗0 and ϕ at sNN−−−−√ = 8.16 TeV are presented along with the new RpPb measurements of K∗0, ϕ , Ξ, and Ω at sNN−−−√ = 5.02 TeV. At intermediate pT (2-8 GeV/c), RpPb of Ξ, Ω show a Cronin-like enhancement, while K∗0 and ϕ show no or little nuclear modification. At high pT (> 8 GeV/c), the RpPb values of all hadrons are consistent with unity within uncertainties. The RpPb of K∗(892)0 and ϕ(1020) at sNN−−−√ = 8.16 and 5.02 TeV show no significant energy dependence.
The production of K∗(892)0 and ϕ(1020) resonances has been measured in p-Pb collisions at sNN−−−√ = 8.16 TeV using the ALICE detector. Resonances are reconstructed via their hadronic decay channels in the rapidity interval −0.5 < y < 0 and the transverse momentum spectra are measured for various multiplicity classes up to pT = 20 GeV/c for K∗(892)0 and pT = 16 GeV/c for ϕ(1020). The pT -integrated yields and mean transverse momenta are reported and compared with previous results in pp, p-Pb and Pb-Pb collisions. The xT scaling for K∗(892)0 and ϕ(1020) resonance production is newly tested in p-Pb collisions and found to hold in the high-pT region at Large Hadron Collider energies. The nuclear modification factors (RpPb) as a function of pT for K∗0 and ϕ at sNN−−−−√ = 8.16 TeV are presented along with the new RpPb measurements of K∗0, ϕ , Ξ, and Ω at sNN−−−√ = 5.02 TeV. At intermediate pT (2-8 GeV/c), RpPb of Ξ, Ω show a Cronin-like enhancement, while K∗0 and ϕ show no or little nuclear modification. At high pT (> 8 GeV/c), the RpPb values of all hadrons are consistent with unity within uncertainties. The RpPb of K∗(892)0 and ϕ(1020) at sNN−−−√ = 8.16 and 5.02 TeV show no significant energy dependence.
First measurements of balance functions (BFs) of all combinations of identified charged hadron (π,K,p) pairs in Pb−Pb collisions at sNN−−−√=2.76 TeV recorded by the ALICE detector are presented. The BF measurements are carried out as two-dimensional differential correlators versus the relative rapidity (Δy) and azimuthal angle (Δφ) of hadron pairs, and studied as a function of collision centrality. The Δφ dependence of BFs is expected to be sensitive to the light quark diffusivity in the quark−gluon plasma. While the BF azimuthal widths of all pairs substantially decrease from peripheral to central collisions, the longitudinal widths exhibit mixed behaviors: BFs of ππ and cross-species pairs narrow significantly in more central collisions, whereas those of KK and pp are found to be independent of collision centrality. This dichotomy is qualitatively consistent with the presence of strong radial flow effects and the existence of two stages of quark production in relativistic heavy-ion collisions. Finally, the first measurements of the collision centrality evolution of BF integrals are presented, with the observation that charge balancing fractions are nearly independent of collision centrality in Pb−Pb collisions. Overall, the results presented provide new and challenging constraints for theoretical models of hadron production and transport in relativistic heavy-ion collisions.
First measurements of balance functions (BFs) of all combinations of identified charged hadron (π,K,p) pairs in Pb−Pb collisions at sNN−−−√=2.76 TeV recorded by the ALICE detector are presented. The BF measurements are carried out as two-dimensional differential correlators versus the relative rapidity (Δy) and azimuthal angle (Δφ) of hadron pairs, and studied as a function of collision centrality. The Δφ dependence of BFs is expected to be sensitive to the light quark diffusivity in the quark−gluon plasma. While the BF azimuthal widths of all pairs substantially decrease from peripheral to central collisions, the longitudinal widths exhibit mixed behaviors: BFs of ππ and cross-species pairs narrow significantly in more central collisions, whereas those of KK and pp are found to be independent of collision centrality. This dichotomy is qualitatively consistent with the presence of strong radial flow effects and the existence of two stages of quark production in relativistic heavy-ion collisions. Finally, the first measurements of the collision centrality evolution of BF integrals are presented, with the observation that charge balancing fractions are nearly independent of collision centrality in Pb−Pb collisions. Overall, the results presented provide new and challenging constraints for theoretical models of hadron production and transport in relativistic heavy-ion collisions.